Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
Public ClinicalTrials.gov record NCT00378131. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Phase II Study Comparing the Safety, Tolerability and Beneficial Effects of Daily Doses of RC-1291 and Placebo in Patients With Cancer Anorexia/Cachexia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced anorexia and cachexia. This placebo controlled study will evaluate the safety and efficacy of RC-1291 HCl in cancer patients with cachexia.
Study identification
- NCT ID
- NCT00378131
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2006 (Type not available)
- Primary completion
- Apr 2007 (Actual)
- Completion
- Apr 2007 (Actual)
- Last update posted
- Sep 2, 2013
2006 – 2007
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Palo Verde Hematology Oncology, Ltd. | Glendale | Arizona | 85304 | — |
| San Diego Pacific Oncology & Hematology Associates | Encinitas | California | 92024 | — |
| Sant P. Chawla, MD | Santa Monica | California | 90403 | — |
| Melbourne Internal Medicine Associates | Melbourne | Florida | 32901 | — |
| Southwest Oncology Associates | Lafayette | Louisiana | 70503 | — |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | — |
| Chesapeake Oncology Hematology Associates, PA | Glen Burnie | Maryland | 21061 | — |
| Beth Israel Cancer Center | New York | New York | 10003 | — |
| Charleston Cancer Center | Charleston | South Carolina | 29406 | — |
| South Carolina Oncology Associates, PA | Columbia | South Carolina | 29210 | — |
| South Carolina Cancer Specialists | Hilton Head Island | South Carolina | 29926 | — |
| University of Texas Medical Branch | Galveston | Texas | 77555 | — |
| Michael E. DeBakey VA Medical Center | Houston | Texas | 77030 | — |
| Cancer Outreach Associates | Abingdon | Virginia | 24211 | — |
| Virginia Cancer Institute | Richmond | Virginia | 23230 | — |
| Multicare Health System | Tacoma | Washington | 98405 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00378131, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2013 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00378131 live on ClinicalTrials.gov.